Parker Waichman LLP

FDA Orders Studies of Inhaled Asthma Drugs

Regulators have mandated that drugmakers conduct clinical trials with a group of 53,000 patients to test the safety of approved, inhaled asthma drugs, said Reuters. We recently wrote that new warnings for the inhaled asthma drugs Advair, Foradil, and Symbicort were just finalized by the U.S. Food & Drug Administration (FDA). Also, we previously wrote […]

Regulators have mandated that drugmakers conduct clinical trials with a group of 53,000 patients to test the safety of approved, <"https://www.yourlawyer.com/practice_areas/defective_drugs">inhaled asthma drugs, said Reuters.

We recently wrote that new warnings for the inhaled asthma drugs <"https://www.yourlawyer.com/topics/overview/advair">Advair, <"https://www.yourlawyer.com/topics/overview/Foradil">Foradil, and Symbicort were just finalized by the U.S. Food & Drug Administration (FDA). Also, we previously wrote that the agency was planning on requiring the manufacturers of LABAs to conduct additional studies to further evaluate the safety of LABAs when used in combination with inhaled corticosteroids. The FDA sought information on the design of these studies at a public advisory committee meeting in March 2010.

The trials have been required on a controversial drug class known as long-acting beta-agonists (LABAs) used in conjunction with inhaled steroids, an asthma drug class, the FDA just announced, said Reuters. The LABAs involved in the study are AstraZeneca’s Symbicort, GlaxoSmithKline’s Advair Diskus, Merck & Co’s Dulera, and Novartis AG’s Foradil. These drugs have been a concern of the FDA for some time because they can “increase the risk of severely worsening asthma symptoms” and have been linked to hospitalizations and death, noted Reuters.

LABAs prevent the release of substances in the body that cause inflammation of airways in the lungs. Advair and Symbicort use a LABA with an inhaled steroid; <"https://www.yourlawyer.com/topics/overview/serevent">Serevent and Foradil (made by Novartis and marketed by Merck & Co in the U.S.) only contain LABAs. These drugs are approved to treat people whose asthma isn’t well controlled by other drugs including inhaled corticosteroids.

Study results are expected in 2017; the study will begin this year. Four of the trials will involve the LABAs plus a corticosteroid and will be compared with steroid use alone; patients will be 2 years of age and older, said Reuters, adding that these studies will involve 46,800 patients. The other trial of 6,200 younger patients—aged 4 to 11—will look at Glaxo’s Advair Diskus.

Reuters said the large study size points to the FDA’s concern about the safety of these drugs and the fact that there is such a large patient base involved.

Meanwhile, the recent recommendations do not apply to the use of LABAs for COPD therapy, another approved use of the drugs. The FDA has been reviewing LABAs for the past several years, and their labels had already warned that they could increase the risk of asthma related death. In February, the FDA said it was aiming to reduce the use of the drugs, and that they should only be used in the sickest asthma patients.

The new warnings are aimed at informing both doctors and patients about how the products should ideally be used. The label warnings are effective immediately and will be online, but it was unclear how long it would take for the new cautions to be added to actual products, the FDA said

Both Glaxo and AstraZeneca had resisted the changes, which caused the FDA to order them to do so, using authority Congress granted it in a 2007 law. This marks the eighth time the agency has used its new powers, Reuters said.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Thank you Parker Waichman. Working with Christina Morace through this long process made it easy and rewarding. Always pleasant to speak with and answered any of my questions and concerns. She kept me informed on all the documents needed on a timely basis and all the updates on my case. I sincerely recommend this Law Firm for the professional and knowledgeable workers. Thank you Carrie Hargrove Erskine
Carrie Hargrove
4 months ago
5 Star Reviews 150
Edward Mooney
6 years ago
5 Star Reviews 150
I would love to thank the law firm of Parker and Waichman LLP and Especially Shelly Davis who were very kind and helpful to my mother Maria. My mom can't stop speaking enough positive things about Ms. Davis the legal assistant and how comforting and helpful she was, Thank you once again for all you have done to help my elderly mother resolve her legal affairs
Avi Gringuz
2 months ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038